Seizure in Patient with Neurofibromatosis and Amygdala Low-Grade Glioma

Joseph A Carnevale1, Jacob L Goldberg1, Theodore Schwartz1

  • 1Department of Neurological Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, USA.

World Neurosurgery
|October 2, 2021
PubMed

Insights

This case highlights a rare instance of low-grade glioma in a patient with neurofibromatosis type 1, presenting with drug-resistant epilepsy. Surgical intervention for the temporal lobe tumor improved seizure control.

Area of Science:

  • Neurology
  • Oncology
  • Genetics

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder associated with an increased risk of various tumors, including gliomas.
  • Epilepsy is a common neurological complication in patients with NF1, often linked to brain abnormalities.

Observation:

  • A 31-year-old male with NF1 and a history of epilepsy presented with worsening seizure frequency.
  • Clinical examination revealed cafe au lait spots and Lisch nodules, characteristic of NF1.
  • EEG and MRI identified a right amygdala mass, suggestive of a neoplastic process.

Findings:

  • The patient underwent right amygdalohippocampectomy for the temporal lobe mass.
  • Pathological examination confirmed a low-grade glioma with specific cellular characteristics.
  • Preoperative Wada testing indicated left-hemisphere dominance for language and memory.

Implications:

  • This case underscores the importance of considering low-grade gliomas in NF1 patients with refractory epilepsy.
  • Early diagnosis and appropriate management, including surgical resection, are crucial for seizure control and patient outcomes.
  • Further research into the specific oncogenic pathways in NF1-associated gliomas may lead to targeted therapies.